UBS’s Covisint Corporation COVS Stock Holding History

UBS’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-839	Closed	-$4K	–	11075
2014 Q2	$4K	Sell	839 -4,751	-85%	-$29.7K	﹤0.01%	9742
2014 Q1	$41K	Buy	+5,590	New	+$56.2K	﹤0.01%	7128

Other funds holding COVS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Neuberger Berman Group

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

LionEye Capital Management New York $57.4M AUM 28.02% 1-Year Est. Return

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Loeb Offshore Management New York $547M AUM 50.11% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

UBS's COVS Position: Q3 2014 in Review

UBS sold out of Covisint Corporation (COVS) in Q3 2014, closing a stake of 839 shares — an estimated $4K sold.

UBS first reported a position in COVS in Q1 2014 and held it in 2 quarters. The position peaked at $41K in Q1 2014. 41 funds tracked by Wall St. Rank hold COVS as of Q3 2014.

UBS reported no remaining Covisint Corporation position as of Q3 2014 after selling out during the quarter.
UBS sold 839 Covisint Corporation shares in Q3 2014, an estimated $4K.
UBS first reported a position in Covisint Corporation in Q1 2014 and held it in 2 quarters.
UBS's Covisint Corporation position peaked at $41K in Q1 2014.
41 funds tracked by Wall St. Rank held Covisint Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.